American Century Companies Inc. Raises Stock Holdings in Embecta Corp. (NASDAQ:EMBC)

American Century Companies Inc. lifted its holdings in Embecta Corp. (NASDAQ:EMBC) by 8.0% in the fourth quarter, HoldingsChannel reports. The firm owned 3,261,934 shares of the company’s stock after purchasing an additional 242,668 shares during the quarter. American Century Companies Inc. owned 0.06% of Embecta worth $67,359,000 at the end of the most recent reporting period.

Several other large investors also recently bought and sold shares of the business. Natixis Advisors LLC increased its stake in Embecta by 5.7% during the third quarter. Natixis Advisors LLC now owns 30,735 shares of the company’s stock worth $433,000 after acquiring an additional 1,648 shares during the last quarter. Quest Partners LLC purchased a new position in shares of Embecta in the 3rd quarter worth approximately $239,000. Intech Investment Management LLC bought a new position in shares of Embecta during the 3rd quarter valued at approximately $211,000. Rubric Capital Management LP purchased a new stake in Embecta during the 3rd quarter valued at $15,306,000. Finally, Rockefeller Capital Management L.P. lifted its position in Embecta by 3.7% in the third quarter. Rockefeller Capital Management L.P. now owns 90,072 shares of the company’s stock worth $1,270,000 after buying an additional 3,231 shares during the last quarter. Institutional investors own 93.83% of the company’s stock.

Wall Street Analyst Weigh In

Several equities research analysts have recently issued reports on EMBC shares. BTIG Research upgraded shares of Embecta from a “neutral” rating to a “buy” rating and set a $26.00 target price for the company in a report on Wednesday, November 27th. Morgan Stanley upgraded Embecta from an “underweight” rating to an “equal weight” rating and boosted their target price for the company from $13.00 to $20.00 in a research report on Monday, December 2nd.

Embecta Trading Down 1.6 %

Shares of EMBC opened at $12.65 on Wednesday. The firm has a market capitalization of $735.40 million, a P/E ratio of 12.65, a P/E/G ratio of 0.78 and a beta of 1.27. Embecta Corp. has a 12-month low of $9.93 and a 12-month high of $21.48. The firm has a fifty day moving average price of $15.65 and a 200-day moving average price of $16.34.

Embecta (NASDAQ:EMBC) last issued its earnings results on Thursday, February 6th. The company reported $0.65 EPS for the quarter, topping analysts’ consensus estimates of $0.45 by $0.20. Embecta had a net margin of 5.25% and a negative return on equity of 19.22%. Analysts predict that Embecta Corp. will post 2.85 earnings per share for the current year.

Embecta Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, March 14th. Shareholders of record on Friday, February 28th were given a dividend of $0.15 per share. This represents a $0.60 dividend on an annualized basis and a yield of 4.74%. The ex-dividend date was Friday, February 28th. Embecta’s dividend payout ratio (DPR) is presently 60.00%.

Insiders Place Their Bets

In other news, Director Milton Mayo Morris sold 3,100 shares of the business’s stock in a transaction dated Thursday, February 13th. The shares were sold at an average price of $16.38, for a total value of $50,778.00. Following the completion of the sale, the director now owns 36,133 shares in the company, valued at approximately $591,858.54. The trade was a 7.90 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Company insiders own 0.42% of the company’s stock.

Embecta Company Profile

Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes.